Cholangiocyte biology

Current Opinion in Gastroenterology

Volumn 22, Issue 3, 2006, Pages 279-287

  Tietz, Pamela S ^a   LaRusso, Nicholas F ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

Cholangiocyte; Cholangiopathies; Receptors; Secretion; Transport

Indexed keywords

CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN A; GLIBENCLAMIDE; INTERLEUKIN 2 RECEPTOR ANTIBODY; MYCOPHENOLIC ACID; PREDNISONE; PSORALEN; STEROID; TACROLIMUS; THALIDOMIDE; THYMOCYTE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; URSODEOXYCHOLIC ACID;

ACUTE GRAFT REJECTION; ALAGILLE SYNDROME; AUTOIMMUNE DISEASE; BILE DUCT ATRESIA; BILE DUCT CARCINOMA; BILE DUCT DISEASE; BILE SECRETION; BIOLOGY; BIOTECHNOLOGY; BRACHYTHERAPY; CANCER SURGERY; CELL PROLIFERATION; CELL PROTECTION; CELL SECRETION; CHOLANGITIS; CHOLESTASIS; CHRONIC GRAFT REJECTION; CRYPTOSPORIDIUM PARVUM; CYSTIC FIBROSIS; DISEASE MODEL; DRUG MECHANISM; EPITHELIUM; EXPERIMENTAL MODEL; GENE SILENCING; GRAFT DYSFUNCTION; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HUMAN; ION TRANSPORT; KIDNEY GRAFT; KIDNEY POLYCYSTIC DISEASE; LIVER DISEASE; LIVER FIBROSIS; LIVER GRAFT; LIVER POLYCYSTIC DISEASE; LIVER TRANSPLANTATION; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; NONHUMAN; PARTIAL HEPATECTOMY; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PROTEIN FUNCTION; PUVA; REVIEW; SARCOIDOSIS; SIGNAL TRANSDUCTION; SOLUTE; WATER TRANSPORT;

ANIMALS; BILE; BILE DUCT DISEASES; BILE DUCTS; CELL PROLIFERATION; CYTOPROTECTION; HUMANS;

EID: 33746261418     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mog.0000218965.78558.bc     Document Type: Review

References (18)

1. Strazzabosco M, Fabris L, Spirli C. Pathophysiology of cholangiopathies. J Clin Gastroenterol 2005; 39 (Suppl 2):S90-S102. This excellent review highlights a classification of cholangiopathies, along with the respective potential to evolve to chronic progressive liver disease and the current therapeutic approaches.
2. Lazaridis KN, Strazzabosco M, Larusso NF. The cholangiopathies: disorders of biliary epithelia. Gastroenterology 2004; 127:1565-1577.
3. Lazaridis KN, Gores GJ. Cholangiocarcinoma. Gastroenterology 2005; 128:1655-1667.
4. Adams DH, Afford SC. Effector mechanisms of nonsuppurative destructive cholangitis in graft-versus-host disease and allograft rejection. Semin Liver Dis 2005; 25:281-297.
5. Alvaro D, Invernizzi P, Onori P, et al. Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis. J Hepatol 2004; 41:905-912.
6. Ishimura N, Isomoto H, Bronk SF, Gores GJ. TRAIL induces cell migration and invasion in apoptosis-resistant cholangiocarcinoma cells. Am J Physiol Gastrointest Liver Physiol 2006; 290:G129-G136.
7. Wang L, Piguet AC, Schmidt K, et al. Activation of CREB by tauroursodeoxycholic acid protects cholangiocytes from apoptosis induced by mTOR inhibition. Hepatology 2005; 41:1241-1251.
8. Alpini G, Glaser S, Baiocchi L, et al. Secretin activation of the apical Na+-dependent bile acid transporter is associated with cholehepatic shunting in rats. Hepatology 2005; 41:1037-1045.
9. Spirli C, Fiorotto R, Song L, et al. Glibenclamide stimulates fluid secretion in rodent cholangiocytes through a cystic fibrosis transmembrane conductance regulator-independent mechanism. Gastroenterology 2005; 129: 220-233.
10. Doctor RB, Matzakos T, McWilliams R, et al. Purinergic regulation of cholangiocyte secretion: identification of a novel role for P2X receptors. Am J Physiol Gastrointest Liver Physiol 2005; 288:G779-G786. A paper describing P2X receptors in cholangiocytes and their contribution to local regulation of biliary secretion and bile formation.
11. Marzioni M, Glaser S, Francis H, et al. Autocrine/paracrine regulation of the growth of the biliary tree by the neuroendocrine hormone serotonin. Gastroenterology 2005; 128:121-137.
12. Taffetani S, Ueno Y, Meng F, et al. Tannic acid inhibits cholangiocyte proliferation after bile duct ligation via a cyclic adenosine 5′,3′-monophosphate-dependent pathway. Am J Pathol 2005; 166:1671-1679.
13. Tietz PS, McNiven MA, Splinter PL, et al. Cytoskeletal and motor proteins facilitate trafficking of AQP1-containing vesicles in cholangiocytes. Biol Cell 2006; 98:43-52.
14. Chen XM, O'Hara SP, Huang BQ, et al. Apical organelle discharge by Cryptosporidium parvum is temperature, cytoskeleton, and intracellular calcium dependent and required for host cell invasion. Infect Immun 2004; 72:6806-6816. This paper explores the mechanisms of apical organelle discharge by C. parvum sporozoites.
15. Chen XM, O'Hara SP, Huang BQ, et al. Localized glucose and water influx facilitates Cryptosporidium parvum cellular invasion by means of modulation of host-cell membrane protrusion. Proc Natl Acad Sci USA 2005; 102:6338-6343. Glucose-driven, aquaporin-mediated localized water influx is involved in the membrane protrusion during C. parvum cellular invasion; a phenomenon relevant to the mechanisms of cell membrane protrusion, which represents a novel finding.
16. Masyuk TV, Huang BQ, Masyuk Al, et al. Biliary dysgenesis in the PCK rat, an orthologous model of autosomal recessive polycystic kidney disease. Am J Pathol 2004; 165:1719-1730.
17. Moser M, Matthiesen S, Kirfel J, et al. A mouse model for cystic biliary dysgenesis in autosomal recessive polycystic kidney disease (ARPKD). Hepatology 2005; 41:1113-1121. A description of the first mouse strain, generated by a targeted mutation of Pkhd1.
18. Beaussier M, Wendum D, Fouassier L, et al. Adaptative bile duct proliferative response in experimental bile duct ischemia. J Hepatol 2005; 42:257-265.